Tempus AI Inc. (TEM)
undefined
undefined%
At close: undefined
41.11
0.46%
After-hours Dec 13, 2024, 07:59 PM EST

Company Description

Tempus AI, Inc operates as a healthcare technology company.

It engages in providing next generation sequencing diagnostics, polymerase chain reaction profiling, molecular genotyping, and other anatomic and molecular pathology testing to healthcare providers, pharmaceutical companies, biotechnology companies, researchers, and other third parties.

The company also offers Insights, a license library of linked clinical, molecular, and imaging de-identified data, as well as a suite of analytical services to analytic and cloud-and-compute tools to pharmaceutical and biotechnology companies; and Trials that provides clinical trial matching services to pharmaceutical companies.

In addition, it operates Next; Algos, a suite of algorithmic tests in oncology; Hub, a desktop and mobile platform for ordering, managing, and receiving tests and patient results; and Lens, a platform for researchers and scientists to find, access, and analyze Tempus data.

The company was formerly known as Tempus Labs, Inc. and changed its name to Tempus AI, Inc in January 2023.

Tempus AI, Inc was incorporated in 2015 and is headquartered in Chicago, Illinois.

Tempus AI Inc.
Tempus AI Inc. logo
Country United States
IPO Date Mar 28, 2012
Industry Medical - Diagnostics & Research
Sector Healthcare
Employees 2,300
CEO Eric P. Lefkofsky

Contact Details

Address:
600 West Chicago Avenue
Chicago, Illinois
United States
Website https://www.tempus.com

Stock Details

Ticker Symbol n/a
Exchange NASDAQ
Fiscal Year n/a
Reporting Currency USD
CIK Code n/a
CUSIP Number 71535D106
ISIN Number US88023B1035
Employer ID -
SIC Code n/a

Key Executives

Name Position
Eric P. Lefkofsky Co-Founder, Chief Executive Officer, President & Chairman
James Rogers Chief Financial Officer
Ryan Fukushima Chief Operating Officer
Shane Colley Chief Technology Officer
Stacey Kraft Chief People Officer
Christina Antoniou Senior Vice President & Head of Corporate Development
Dr. Kate A. Sasser Ph.D. Chief Scientific Officer
Erik Phelps Executive Vice President, Assistant Secretary and Chief Administrative & Legal Officer
Patty Spiller Senior Vice President of Marketing
Ryan M. Bartolucci CPA Chief Accounting Officer

Latest SEC Filings

No SEC filings available.